Myotonic muscular dystrophy is a disorder of humans that involves many organ systems. Physiological studies have suggested that the fundamental defect is of membrane origin. Heretofore, no reproducible metabolic abnormalities have been demonstrated. In the present studies we used erythrocyte ghosts as a convenient source of purified membranes that do not possess changes of denervation, dystrophy, and fibrosis that might complicate the interpretation of muscle membrane changes. Our experiments demonstrated a significant difference in the phosphorylation of erythrocyte ghost protein by [y_32PJATP, with endogenous protein kinase of erythrocyte membrane as the enzyme source. After ghosts were kept for 1 week at -20°, phosphorylation of membrane protein in eight controls was twice as high as endogenous protein kinase activity measured in fresh preparations. No stimulation was seen in preparations from seven myotonic dystrophy patients from three different families. This reproducible difference in normal and myotonic membranes may represent an important new approach to studies of this debilitating inborn error of metabolism.
[y_32PJATP, with endogenous protein kinase of erythrocyte membrane as the enzyme source. After ghosts were kept for 1 week at -20°, phosphorylation of membrane protein in eight controls was twice as high as endogenous protein kinase activity measured in fresh preparations. No stimulation was seen in preparations from seven myotonic dystrophy patients from three different families. This reproducible difference in normal and myotonic membranes may represent an important new approach to studies of this debilitating inborn error of metabolism.
Myotonic dystrophy is a systemic disorder inherited as an autosomal dominant trait. Although weakness, myotonia, and a progressive dystrophy of striated muscle are principle manifestations of the disease (1), abnormalities occur in other tissues: malformation of cranial bones (2) , extrathyroid hypometabolism (1) (2) (3) (4) (5) , alopecia (1), testicular atrophy (2, 4, 5) , and abnormal glucose tolerance with enhanced insulin levels (2, 4, 6) . Abnormal electrocardiograms frequently associated with cardiac symptoms (7, 8) , disturbances of smooth-muscle motility (9) (10) (11) (12) , subcapsular irridescent cataracts (1) , and hypercatabolism of IgG (13) have been reported. Physiological investigations have suggested a membrane abnormality as the underlying metabolic defect. Repetitive depolarization of myotonic muscle fibers, even after nerve block or neuromuscular blockade, has led many investigators to localize the defect to the muscle sarcolemma (14) (15) (16) (17) . No abnormalities in muscle contractile proteins (18) or in "relaxing factor" (19) have been demonstrated in myotonic muscle tissue. No information is available on the metabolic error responsible for this membrane defect.
Although muscle is one of the principle target organs, the delineation of the primary biochemical defect is made extremely difficult on minimal biopsy material by the presence of atrophy, fibrous tissue, and changes of denervation that may result in multiple secondary biochemical changes, and by the small yield and impurity of isolated sarcolemma. destained with 7% acetic acid, the individual polypeptide bands were cut into discs less than 3 mm, solubilized, and assayed for radioactivity (22, 27 Unstained sodium dodecyl sulfate-polyacrylamide gels and gels stained with Coomassie Blue were scanned with a Gilford spectrophotometer and a model 2410S linear transport accessory. Gels were scanned through a 0.05-mm slit at 280 nm for unstained and 550 nm for stained gels. The relative peak areas were obtained (22, 28) . The bands were designated by Roman numerals (22) (Fig. 1) . Purified F2C histone, containing 9.4% serine and 2.1% threonine and migrating on sodium dodecyl sulfate-polyacrylamide gels as a single band of molecular weight 16,000-19,000, was kindly supplied by Dr. Lee Sanders (29) . F2C histone was identified on gels by its relative migration and its incorporation of 32p. No activity was seen in control or myotonic gels in this molecular-weight region.
In order to study 32p release from phosphoprotein, intact erythrocytes were incubated with NaH2 32PO4 (30) for 1 hr. Ghosts were prepared as described above. Aliquots of these membranes were subjected to electrophoresis on sodium dodecyl sulfate-polyacrylamide gels after acute freezethawing and storage for 1 week at -20°. 82p release by phosphorylation was also measured by incubating these phosphorylated ghosts in identical assay mixtures (described above), containing unlabeled ATP instead of [y-'2PJATP.
Phospholipids were extracted from ghost preparations (31) . Separation of phospholipids by two-dimensional thin-layer chromatography was performed on Supelco Redicoats by a modification of the method of Rouser et al. (32, 33) . Phosphate was determined by a modification of the procedure of Lowry et al. (33, 34) . Extraction of gangliosides and thinlayer chromatographic profiles were performed (35) . For determination of total ganglioside sialic acid, the aqueous phase was dialyzed for 3 days against 5 mM NH40H. Protein and ganglioside sialic acid was assessed after hydrolysis in 0.1 M H2SO4 at 80°for 1 hr (36). ATPases were assayed by the method of Wins and Schoffeniels (44) .
ATP and cyclic AMP were purchased as sodium salts from 
Once the myotonic ghosts had been aged at -20°for 1 week, no subsequent freezing or thawing could enhance activity.
The differences in total phosphorylation were clearly demonstrated in the phosphorylation of each individual membrane component. In the aged frozen preparations of ghosts from myotonic patients, each separate component was phosphorylated about half as much as control preparations (Table 2 ). These differences in phosphorylation between normal and myotonic preparations were noted even though no differences could be demonstrated in relative amounts of the polypeptides present or in the distribution of phosphorylation among the components. Furthermore, although the rate of [32P]protein phosphorylation was different in normal and myotonic preparations, there were no differences in the amounts of protein phosphates as assessed by colorimetric analyses.
Cyclic AMP stimulated the transfer of 32p from [y-32P]ATP to several protein components ( Table 2 ). Under initial rate conditions, there was no cyclic AMP stimulation of components I and II and a modest 20-25% stimulation in component V in both control and myotonic groups. 32p transfer to the minor polypeptide bands was enhanced to a much more significant extent by the addition of cyclic AMP. In the absence of cyclic AMP, phosphorylation of IVb was significantly decreased in myotonic preparations, whereas in the presence of cyclic AMP, phosphorylation of IVb was identical in both normal and myotonic ghost preparations. Thus, although cyclic AMP stimulation is most marked in the minor components of both normal and myotonic preparations, there is an apparent greater cyclic AMP stimulation in the myotonic membranes. However, no significant differences were noted in Erythrocyte ghosts were treated as described in Table 1 in the absence or presence of 2.5 ,M cAMP. Incorporation of 32p is expressed as the mean + SEM. P represents the significance of the difference between each component in the normal and myotonic populations. Components I through V incorporated more than 94% of the total incorporation into phosphoprotein in both myotonic and control preparations in all experiments. (Table 2) .
Individual components of fresh and acute frozen preparations demonstrated no significant differences between control and myotonic ghosts ( Table 3 ). The 40% increase in tota phosphorylation of acute frozen control membranes and the 100% increase in acute frozen myotonic membranes were reflected in each of the individual components (Table 3) . Purified F2C histone was used to determine whether the phosphorylation differences of aged ghosts were observed with exogenous substrate. Phosphorylation of F2C histone was not significantly different under any of the membrane states described. In fact, the same aged myotonic ghosts that demonstrated a diminution in endogenous substrate phosphorylation possessed an F2C histone kinase activity stimulated by cyclic AMP that appeared suggestively higher, although the latter was not statistically significant (Table 4) .
Mixing experiments with aged frozen preparations failed to demonstrate the presence of a soluble activator or an inhibitor. All combinations resulted in strictly additive phosphorylation. Furthermore, studies of the Km for ATP yielded identical values of 8 MuM for phosphorylation of both normal and myotonic ghost preparations. The total phospholipid content was about 27 ,ug of phosphate per mg of protein in both preparations, and the two-dimensional thin-layer chromatograms of the phospholipids were identical for both preparations. In addition, magnesium ATPase, calcium ATPase, and sodium, potassium, magnesium ATPase were equivalent in the two preparations. The ganglioside sialic acid, as well as protein sialic acid, concentrations were also equivalent.
Measurements of 32p release from ghosts prepared from labeled erythrocytes demonstrated insignificant breakdown of phosphoprotein when frozen acutely or for 1 week at -20°. Incubation of these labeled proteins under assay conditions demonstrated negligible phosphoprotein phosphatase activity associated with membrane in both normal and myotonic ghost preparations.
DISCUSSION
In this paper we have demonstrated for the first time a reproducible abnormality in membrane-bound protein kinase of erythrocyte ghosts from patients with myotonic dystrophy. This abnormality cannot be attributed to secondary changes such as denervation, fibrosis, and dystrophy, which might be implicated if muscle tissue were examined. Furthermore, there are no known physiological or clinical abnormalities reported in erythrocytes of patients with myotonic dystrophy. A previous report of abnormalities in erythrocyte ATPase activity and its ouabain inhibition has not been verified in other laboratories, including our own (38) . No differences could be demonstrated in our laboratory in phospholipids, gangliosides, or sialoproteins, or in the membrane polypeptide electrophoretic profiles with control and myotonic ghost preparations. The diminution in endogenous erythrocyte protein kinase cannot be attributed to differences in substrate since the Km for ATP is identical and the polypeptides to be phosphorylated are qualitatively and quantitatively identical in normal and myotonic preparations. The ability of acute frozen erythrocyte polypeptides from myotonic patients to be phosphorylated at twice the rate noted in fresh or aged frozen preparations would also suggest that the amounts of protein substrate are not responsible for the differences noted in enzyme activity.
From the present data it is unclear whether the diminished protein kinase activity in aged frozen myotonic preparations is due to an intrinsic change in enzyme protein or to a change in the state of the membrane associated with a less-stable configuration of the enzyme protein or with an altered reactivity with its specific substrates. During freezing, lipid solidification and freeze dehydration may cause severe cellular structural disturbances (39) . The rate of freezing influences the amount of membrane-bound sodium,potassium ATPase (40, 41) . These changes have been attributed to altered protein-lipid interactions (42) , as well as to permeability of the substrates. Similar differences in protein-lipid interactions and substrate accessibility in normal and myotonic erythrocyte membranes may be responsible for the altered endogenous protein kinase activity in aged frozen preparations, although no direct evidence has been provided to support this suggestion. The mixing experiments exclude a soluble inhibitor but in no sense exclude membrane-bound inhibitors. The difference in enzyme activity cannot be attributed simply to gross changes in phospholipids or gangliosides, since their total and individual amounts were the same in both normal and myotonic preparations.
Various theories have been proposed for the role of membrane-bound protein kinase in synapse membranes (21) ; its role in erythrocytes is unknown. Differences in specific buffers and their concentrations, as well as ionic constituents and substrates, appear to influence enzyme activity (22) (23) (24) . Furthermore, the number of such protein kinases present in erythrocyte membranes is not known. The diminution in kinase activity in myotonic aged frozen ghosts is only present with endogenous substate and is not noted when F2C is used. Such data may signify two different enzymes only one of which, namely the endogenous protein kinase, is altered in myotonic erythrocytes, while the histone kinase is preserved. However, the differences might also be explained as an altered activity toward membrane-bound substrates and not towards exogenous substrates; and only one catalytic species might be present with different reactivity to different substrates.
The protein kinase in erythrocytes may be a remnant of a control system lost during cell maturation. The abnormality in endogenous protein kinase of ghost preparations from myotonic patients may thus reflect a more general membrane abnormality with significant effects in excitable tissue. Muscle membrane has been implicated as the site of the physiological defect. After nerve block or isolation of myotonic muscle in vitro, repetitive depolarization of myotonic muscle can still be elicited (14) (15) (16) (17) . Recent studies have demonstrated abnormal cable properties in muscle from patients with myotonia congenita, but the only electrophysiologic correlate observed in muscle from myotonic dystrophy patients was an increase in total fiber capacitance (43) . The erythrocyte data cannot be related to muscle changes without further clarification of membrane-bound protein kinase in muscle tissue, and the extent of involvement of erythrocyte membrane in the disease process.
This investigation was supported in part by grants from the National Multiple Sclerosis Society, 558-C-4, the National Institutes of Health, NS07872, and by Grant RR30 from the General Clinical Centers Program of the Division of Research Resources, National. Institutes of Health. We thank Ms. Pauline
